Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen [Phase 4]
Phase 4 trial update assessing safety and efficacy of trastuzumab as part of a breast cancer treatment regimen.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Palbociclib and FES PET [Phase 2]
Phase 2 clinical trial update evaluating palbociclib with FES PET in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer [Phase 2, Phase 3]
Clinical trial update for neo-adjuvant chemotherapy in triple negative breast cancer spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the safety and effectiveness of GDC-0032 in combination with tamoxifen for breast cancer has completed…
-
FDA approval · 2022-10-11FDA Approved: RALOXIFENE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for raloxifene hydrochloride from Amneal Pharmaceuticals LLC, authorizing a regulatory change under …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer [Phase 2]
Phase 2 single-arm study evaluating pyrotinib maleate tablets with albumin-bound paclitaxel and trastuzumab as neoadjuvant therapy in HER2-p…
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: 89ZrTrastuzumab Breast Imaging With Positron Emission Tomography [EARLY_Phase 1]
Early-phase clinical trial update of 89Zr-Trastuzumab PET imaging in breast cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC [Phase 2]
Phase 2 clinical trial update investigating HGWD to improve paclitaxel-related neurotoxicity in breast cancer patients.
-
FDA approval · 2022-10-03FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application to offer a Kisqali (ribociclib) and Femara (letrozole) co-pack, enabling combination therapy in brea…
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects [Phase 1]
Phase 1 trial of active immunotherapy OBI-833 (Globo H-CRM197) in metastatic gastric, breast, colorectal, and lung cancer has completed with…
-
CLINICAL_TRIALS trial_result · 2022-09-30Clinical Trial Update: Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT) [Phase 4]
Phase 4 trial update evaluating timing of endocrine therapy and radiation therapy in early-stage breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-30Clinical Trial Update: Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer [Phase 3]
A Phase 3 trial comparing fulvestrant to capecitabine as maintenance therapy after first-line chemotherapy in HR+/HER2- metastatic breast ca…
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread [Phase 2]
This Phase 2 trial update reports results from the XENERA-1 study evaluating Xentuzumab in combination with Everolimus and Exemestane in wom…
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations [Phase 2]
A phase 2 single-arm exploratory trial evaluating pemigatinib in HER2-negative advanced breast cancer with FGFR alterations.
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating Fluzoparib in combination with Chidamide or Camrelizumab for HRD-positive, HER2-negative advanced breast…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer [Phase 2]
Phase 2 trial update investigating anlotinib combined with chemotherapy and neoadjuvant therapy for hormone receptor-positive, HER-2 negativ…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool [NA]
Feasibility study evaluating a breast cancer screening decision support tool; completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery [Phase 2, Phase 3]
A phase 2/3 clinical trial comparing ultrasound-guided rhomboid intercostal block to serratus anterior plane block for analgesia in mastecto…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating nivolumab plus ipilimumab for metastatic hypermutated HER2-negative breast cancer; the study is active but not recr…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial of abemaciclib for RB-positive, triple-negative metastatic breast cancer was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating panitumumab with nab-paclitaxel and carboplatin for HER2-negative inflammatory breast cancer has completed recruitm…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Serratus Plane Versus Paravertebral Nerve Blocks for Breast Surgery [Phase 4]
Phase 4 trial comparing serratus plane block to paravertebral block for breast surgery; results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases [Phase 2]
Phase 2 clinical trial update evaluating utidelone plus bevacizumab for advanced breast cancer with brain metastases.
-
FDA approval · 2022-09-16FDA Approved: ISOSULFAN BLUE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved Isosulfan Blue from Novadoz Pharmaceuticals LLC under an Original Application/ANDA, establishing a generic option for uses such…
-
FDA approval · 2022-09-14FDA Approved: FLUOROURACIL — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for fluorouracil submitted by BluePoint Laboratories, indicating approval of an ANDA supplement. Thi…